Reviews Pemetrexed

Alimta Drug Description
ALIMTA
(pemetrexed disodium) Injection, Powder, Lyophilized, For Solution for Intravenous
Use
DRUG DESCRIPTION



What are the possible side effects of pemetrexed (Alimta)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

pale skin, easy bruising or bleeding, unusual weakness;
fever, chills, body aches, flu symptoms;
white patches or sores inside your mouth or on your lips;
urinating less than usual, or not at all;
chest pain, trouble...
Read All Potential Side Effects for Alimta »




Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H
pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate.
It is a white to almost-white solid with a molecular formula of C20H19N5Na2O6•7H2O
and a molecular weight of 597.49. The structural formula is as follows:








ALIMTA is supplied as a sterile lyophilized powder for intravenous infusion available in single-dose vials. The product is a white to either light yellow or green-yellow lyophilized solid. Each 100-mg or 500-mg vial of ALIMTA contains pemetrexed disodium equivalent to 100 mg pemetrexed and 106 mg mannitol or 500 mg pemetrexed and 500 mg mannitol, respectively. Hydrochloric acid and/or sodium hydroxide may have been added to adjust pH.
Last reviewed on RxList: 7/17/2009




Alimta Drug Description
ALIMTA
(pemetrexed disodium) Injection, Powder, Lyophilized, For Solution for Intravenous
Use
DRUG DESCRIPTION



What are the possible side effects of pemetrexed (Alimta)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

pale skin, easy bruising or bleeding, unusual weakness;
fever, chills, body aches, flu symptoms;
white patches or sores inside your mouth or on your lips;
urinating less than usual, or not at all;
chest pain, trouble...
Read All Potential Side Effects for Alimta »




Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H
pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate.
It is a white to almost-white solid with a molecular formula of C20H19N5Na2O6•7H2O
and a molecular weight of 597.49. The structural formula is as follows:








ALIMTA is supplied as a sterile lyophilized powder for intravenous infusion available in single-dose vials. The product is a white to either light yellow or green-yellow lyophilized solid. Each 100-mg or 500-mg vial of ALIMTA contains pemetrexed disodium equivalent to 100 mg pemetrexed and 106 mg mannitol or 500 mg pemetrexed and 500 mg mannitol, respectively. Hydrochloric acid and/or sodium hydroxide may have been added to adjust pH.
Last reviewed on RxList: 7/17/2009




Alimta Drug Description
ALIMTA
(pemetrexed disodium) Injection, Powder, Lyophilized, For Solution for Intravenous
Use
DRUG DESCRIPTION



What are the possible side effects of pemetrexed (Alimta)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

pale skin, easy bruising or bleeding, unusual weakness;
fever, chills, body aches, flu symptoms;
white patches or sores inside your mouth or on your lips;
urinating less than usual, or not at all;
chest pain, trouble...
Read All Potential Side Effects for Alimta »




Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H
pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate.
It is a white to almost-white solid with a molecular formula of C20H19N5Na2O6•7H2O
and a molecular weight of 597.49. The structural formula is as follows:








ALIMTA is supplied as a sterile lyophilized powder for intravenous infusion available in single-dose vials. The product is a white to either light yellow or green-yellow lyophilized solid. Each 100-mg or 500-mg vial of ALIMTA contains pemetrexed disodium equivalent to 100 mg pemetrexed and 106 mg mannitol or 500 mg pemetrexed and 500 mg mannitol, respectively. Hydrochloric acid and/or sodium hydroxide may have been added to adjust pH.
Last reviewed on RxList: 7/17/2009




Alimta Drug Description
ALIMTA
(pemetrexed disodium) Injection, Powder, Lyophilized, For Solution for Intravenous
Use
DRUG DESCRIPTION



What are the possible side effects of pemetrexed (Alimta)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

pale skin, easy bruising or bleeding, unusual weakness;
fever, chills, body aches, flu symptoms;
white patches or sores inside your mouth or on your lips;
urinating less than usual, or not at all;
chest pain, trouble...
Read All Potential Side Effects for Alimta »




Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H
pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate.
It is a white to almost-white solid with a molecular formula of C20H19N5Na2O6•7H2O
and a molecular weight of 597.49. The structural formula is as follows:








ALIMTA is supplied as a sterile lyophilized powder for intravenous infusion available in single-dose vials. The product is a white to either light yellow or green-yellow lyophilized solid. Each 100-mg or 500-mg vial of ALIMTA contains pemetrexed disodium equivalent to 100 mg pemetrexed and 106 mg mannitol or 500 mg pemetrexed and 500 mg mannitol, respectively. Hydrochloric acid and/or sodium hydroxide may have been added to adjust pH.
Last reviewed on RxList: 7/17/2009




Alimta Drug Description
ALIMTA
(pemetrexed disodium) Injection, Powder, Lyophilized, For Solution for Intravenous
Use
DRUG DESCRIPTION



What are the possible side effects of pemetrexed (Alimta)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

pale skin, easy bruising or bleeding, unusual weakness;
fever, chills, body aches, flu symptoms;
white patches or sores inside your mouth or on your lips;
urinating less than usual, or not at all;
chest pain, trouble...
Read All Potential Side Effects for Alimta »




Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H
pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate.
It is a white to almost-white solid with a molecular formula of C20H19N5Na2O6•7H2O
and a molecular weight of 597.49. The structural formula is as follows:








ALIMTA is supplied as a sterile lyophilized powder for intravenous infusion available in single-dose vials. The product is a white to either light yellow or green-yellow lyophilized solid. Each 100-mg or 500-mg vial of ALIMTA contains pemetrexed disodium equivalent to 100 mg pemetrexed and 106 mg mannitol or 500 mg pemetrexed and 500 mg mannitol, respectively. Hydrochloric acid and/or sodium hydroxide may have been added to adjust pH.
Last reviewed on RxList: 7/17/2009

Lilly Launches Phase III 'GALES' Trial Of ALIMTA (Pemetrexed For Injection) In Small Cell Lung Cancer
  by rognar
Eli Lilly and Company has launched a major clinical trial evaluating ALIMTA (pemetrexed for injection) in extensive-stage small cell lung cancer (SCLC), a devastating and rapidly spreading form […]

Lilly Launches Phase III 'GALES' Trial Of ALIMTA(R) (Pemetrexed For Injection) In Small Cell Lung Cancer
  by rognar
Eli Lilly and Company has launched a major clinical trial evaluating ALIMTA (pemetrexed for injection) in extensive-stage small cell lung cancer (SCLC), a devastating […]

Anti-cancer drug CYT997 update
  by John Caron
Cytopia Limited (ASX: CYT) has commenced dosing patients in the first of a suite of Phase II clinical studies for its vascular disrupting agent (VDA), CYT997. These studies […]

Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma
  by John Caron
PURPOSE: Pemetrexed and gemcitabine have single-agent activity in malignant pleural mesothelioma (MPM). The combination of pemetrexed/gemcitabine has not previously been studied in MPM to our knowledge. PATIENTS AND METHODS: […]

2008 ASCO Annual Meeting Abtracts Highlight Several Drugs That Show Promise Against Drug Resistant Ovarian Cancer
  by Libby's H*O*P*E*
There were several drugs highlighted in clinical trial abstracts presented at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting that demonstrated varying degrees of effectiveness against […]

Advances in First-Line Treatment of Unresectable Non-Small Cell Lung Cancer: Pemetrexed Maintenance Therapy
  by bmirtsching
Chemotherapy is the initial standard-of-care treatment for unresectable (stage IIIB/IV) non-small cell lung cancer (NSCLC).  Based upon historical information, the optimal duration of initial therapy with a platinum […]

Rare Cancer Presentations: Intraspinal Metastasis of Lung Cancer
  by bmirtsching
Author: Barry C. Mirtsching, MD  (Center for Oncology Research & Treatment, PA, Dallas, TX) Spinal column metastasis of solid tumors are not uncommon.  Most of these tumors are extrdural in […]

GOG Reports on Evaluation of Pemetrexed in Treatment of Recurrent Platinum-Resistant Ovarian Cancer
  by Libby's H*O*P*E*
A phase II Gynecologic Oncology Group (GOG) clinical study found that pemetrexed (Altima®)-an antifolate antineoplastic agent that disrupts folate-dependent cell replication metabolic processes-is sufficiently active in the treatment […]

Prostate cancer news reports: Wednesday, August 19
  by Sitemaster
Today's news reports address: Smoking and risk for prostate cancer Assessing risk for a positive second biopsy after a prior negative biopsy Smoking pot won't cure your cancer but ... Pemetrexed not […]

Data uncertainties mean NICE unable to recommend pemetrexed for the maintenance treatment non-small-cell lung cancer
  by rcplondon
NICE is currently appraising the use of pemetrexed for the maintenance treatment of non-small-cell lung cancer. In its draft guidance, published today, NICE does not recommend pemetrexed. However, […]

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma as well as ... Pemetrexed - Wikipedia, the free encyclopedia

About this chemotherapy drug for treatment of lung cancer. Pemetrexed

Pemetrexed Key Terms: Cisplatin , Docetaxel , Folic acid , Malignant pleural mesothelioma , Multitargeted anti-folate , Non-small cell lung cancer , Pemetrexed: Information from Answers.com

This page contains brief information about pemetrexed disodium and a collection of links to more information about the use of this drug, related research results, and ongoing ... Pemetrexed Disodium - National Cancer Institute

Alimta is approved for the treatment of advanced or metastic nonsquamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM). NSCLC Treament, Mesothelioma, MPM, Alimta (pemetrexed for ...

Premetrexed inhibits three enzymes that are required for purine and pyrimidine synthesis. How Pemetrexed Works

All about Pemetrexed. View complete and up to date Pemetrexed information - part of the Drugs.com trusted medication database. Pemetrexed Facts and Comparisons at Drugs.com

Physician reviewed pemetrexed patient information - includes pemetrexed description, dosage and directions. pemetrexed medical facts from Drugs.com

Pemetrexed is an anti-cancer chemotherapy drug. Alimta is the trade name for the generic drug name Pemetrexed. Premetrexed is used in the treatment of malignant mesothelioma, as ... Pemetrexed, Alimta - Chemotherapy Drugs, Chemo Drug Side Effects

pemetrexed, an antineoplastic-antimetabolite. indications This drug is used in combination with cisplatin in the treatment of malignant pleural mesothelioma and as a single ... pemetrexed - definition of pemetrexed in the Medical dictionary ...